PMDA drug package insert
グラアルファ配合点眼液
PMDA Prescription drug · 興和株式会社 · package insert Jun 11, 2024
Key facts
| Brand names | グラアルファ配合点眼液 |
|---|---|
| Nonproprietary names | リパスジル塩酸塩水和物・ブリモニジン酒石酸塩 |
| Companies | 製造販売元／興和株式会社 |
| Product type | Prescription drug |
| Therapeutic category | Rhoキナーゼ阻害薬/α2作動薬配合剤－緑内障・高眼圧症治療剤－ |
| Therapeutic category codes | 871319 |
| YJ codes | 1319826Q1020 |
| Approval numbers | 30400AMX00417 |
| Package insert edition | 第3版 |
| Package insert date | Jun 11, 2024 |
| PMDA document key | 270072_1319826Q1020_1 |
| PMDA company code | 270072 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: